Nifty Pharma Rises 2.16% on Broad-Based Strength
MarketPulse Summary: Nifty Pharma gained 2.16% (563.9 points) to 26710.1. Breadth was strongly positive with 92 of 130 stocks advancing versus 35 declining. Smaller stocks averaged 1.13%, outperforming the top 10 by market cap, which averaged 0.48%.
📊 Key Numbers
📈 Sector Performance
| Metric | Value |
|---|---|
| Index Level | 26,710.10 |
| Previous Close | 26,146.20 |
| Change | +2.16% |
| Change Points | 563.90 |
🎯 What drove the move?
Market reports provided contextual factors around the sector move, but the available evidence does not establish a single confirmed catalyst.
📊 Market Breadth
Across the broader Pharma stock universe used in this analysis, 35 of 130 stocks declined, while 92 advanced and 3 remained unchanged. Decliners represented 26.92%, compared with 70.77% for advancers. The breadth score was 43.85, indicating strongly positive internal conditions. This universe should not be treated as the official index constituent universe unless separately verified.
| Category | Stocks | Share |
|---|---|---|
| Advancing | 92 | 70.77% |
| Declining | 35 | 26.92% |
| Unchanged | 3 | — |
| Breadth Score | 43.85 | |
🏢 Large Caps vs Smaller Stocks
The top 10 companies by market capitalization averaged 0.48%, while smaller stocks averaged 1.13%. The market-cap-weighted change was 0.76%, compared with a median change of 0.78% and a simple average of 1.08%. The leadership condition was large caps underperforming. The divergence indicates that the magnitude of the sector move was concentrated in larger companies.
🚀 Top Gainers
| Stock | LTP | % |
|---|---|---|
|
MANGALAM
Mangalam Drugs And Organics Limited
|
₹34.26 | +7.16% |
|
SMSPHARMA
SMS Pharmaceuticals Limited
|
₹442.95 | +7.06% |
|
SYNCOMF
Syncom Formulations (India) Limited
|
₹20.04 | +6.71% |
|
SHILPAMED
Shilpa Medicare Limited
|
₹1,021.10 | +6.55% |
|
CAPLIPOINT
Caplin Point Laboratories Limited
|
₹2,748.60 | +5.85% |
📉 Top Losers
| Stock | LTP | % |
|---|---|---|
|
MEDICAMEQ
Medicamen Biotech Limited
|
₹328.05 | -5.27% |
|
MEDICO
Medico Remedies Limited
|
₹34.89 | -3.99% |
|
NATCAPSUQ
Natural Capsules Limited
|
₹171.58 | -3.92% |
|
ORTINGLOBE
ORTIN GLOBAL LIMITED
|
₹15.83 | -3.77% |
|
AMBALALSA
Ambalal Sarabhai Enterprises Limited
|
₹39.97 | -3.17% |
🏦 Largest Companies
Among the top gainers, Mangalam Drugs And Organics Limited gained 7.16% to 34.26, SMS Pharmaceuticals Limited gained 7.06% to 442.95, Syncom Formulations (India) Limited gained 6.71% to 20.04. On the losing side, Medicamen Biotech Limited fell 5.27% to 328.05, Medico Remedies Limited fell 3.99% to 34.89, Natural Capsules Limited fell 3.92% to 171.58. Among the largest companies, Sun Pharmaceutical Industries Limited declined 1.61%, Divi's Laboratories Limited gained 0.56%, Torrent Pharmaceuticals Limited declined 0.72%, Zydus Lifesciences Limited gained 2.19%, Cipla Limited gained 1.32%. The available research does not establish specific reasons for individual stock moves.
| Stock | Market Cap | LTP | % |
|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
4,60,672cr | ₹1,837.30 | -1.61% |
|
DIVISLAB
Divi's Laboratories Limited
|
2,45,266cr | ₹9,375.00 | +0.56% |
|
TORNTPHARM
Torrent Pharmaceuticals Limited
|
1,92,086cr | ₹4,840.00 | -0.72% |
|
ZYDUSLIFE
Zydus Lifesciences Limited
|
1,18,803cr | ₹1,160.00 | +2.19% |
|
CIPLA
Cipla Limited
|
1,14,999cr | ₹1,394.50 | +1.32% |
|
LAURUSLABS
Laurus Labs Limited
|
1,04,740cr | ₹1,954.00 | +0.30% |
|
LUPIN
Lupin Limited
|
99,295cr | ₹2,083.00 | -0.72% |
|
MANKIND
Mankind Pharma Limited
|
98,413cr | ₹2,300.70 | +0.03% |
|
DRREDDY
Dr. Reddy's Laboratories Limited
|
98,325cr | ₹1,185.00 | +0.85% |
|
AUROPHARMA
Aurobindo Pharma Limited
|
94,667cr | ₹1,734.00 | +2.60% |
📝 What the data suggests
Broad-Based Pharma Sector Strength
The data indicates broad-based pharma sector strength. Sector breadth was negative, but the magnitude of the move was concentrated in large-cap stocks. The market-cap-weighted change of 0.76% was weaker than the median change of 0.78%, while the simple average was 1.08%. This indicates that larger companies had the strongest downward influence on the sector index.
👀 What to watch next
The divergence between large-cap and smaller stocks remains relevant to the sector's internal structure. The broad-based pharma sector strength remains the key data-supported theme.
📊 Track Live Markets
Real-time Nifty data, sector performance, market breadth, stock movers and AI-powered analysis.
Open Dashboard →Data generated at 18 Sept 2026. Not investment advice.